In deliveryUnited KingdomGoodsFramework agreement£85,785,000
NHS National Framework Agreement for Omalizumab
- Published
- Published 26 August 2025
- Deadline
- Closed 30 October 2025
Overview
Project title: NHS National Framework for Omalizumab commencing 1st February 2026
Offer reference number: CM/TNS/25/5734
Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £85,785,000
- Procedure
- Open
- Contract type
- Framework agreement
- SME suitable
- Yes
- Published
- 26 August 2025
- Questions by
- 23 October 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- £174,866,000
- Award date
- 26 November 2025
- Contract period
- 1 February 2026 → 31 August 2027
- CELLTRION HEALTHCARE UNITED KINGDOM LIMITED
- Celltrion Healthcare United Kingdom Limited
- MERCURY PHARMACEUTICALS LIMITED
- NOVARTIS PHARMACEUTICALS UK LIMITED
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
30 December 2025
View notice ↗Contract
28 November 2025
View notice ↗Contract Notice
3 October 2025
View notice ↗Prior Information Notice
26 August 2025
View notice ↗
Contracting authority
NHS England
BuyerLondon, United Kingdom
GB-PPON: PDPT-3135-BWWY
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.